Skip to main content
Premium Trial:

Request an Annual Quote

Vaccine Facility Plans

Moderna is to build an mRNA vaccine manufacturing facility as part of a £1 billion (US $1.2 billion) deal with the UK government, the Financial Times reports.

It adds that the deal is part of a governmental push to have access to "homegrown" vaccine supplies in the case of another pandemic. Under the terms of the 10-year deal, which is to be finalized this summer, the facility is to manufacture 250 million vaccine doses per year, FT adds. According to the Wall Street Journal, Moderna says the facility will not only produce COVID-19 vaccines but also likely manufacture other mRNA vaccines it has in development, including ones against seasonal influenza and respiratory syncytial virus.

Sajid Javid, the UK health secretary, tells FT that the COVID-19 pandemic has underscored the need for resiliency. "There will be future pandemics," he says there. "None of us knows exactly what, when, and how."

The Journal adds that this facility would be Moderna's largest manufacturing outside the US and notes that the company has also revealed plans to build facilities in Australia, Canada, and Kenya.

Filed under

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.